These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19357103)

  • 21. Heparin-induced antibodies and cardiovascular risk in patients on dialysis.
    Asmis LM; Segal JB; Plantinga LC; Fink NE; Kerman JS; Kickler TS; Coresh J; Gardner LB
    Thromb Haemost; 2008 Sep; 100(3):498-504. PubMed ID: 18766268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
    Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
    Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis.
    Skouri H; Gandouz R; Abroug S; Kraiem I; Euch H; Gargouri J; Harbi A
    Am J Hematol; 2006 May; 81(5):328-34. PubMed ID: 16628723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.
    Carrier M; Rodger MA; Fergusson D; Doucette S; Kovacs MJ; Moore J; Kelton JG; Knoll GA
    Kidney Int; 2008 Jan; 73(2):213-9. PubMed ID: 17943076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia.
    Warkentin TE; Makris M; Jay RM; Kelton JG
    Am J Med; 2008 Jul; 121(7):632-6. PubMed ID: 18589060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
    Janatpour KA; Gosselin RC; Dager WE; Lee A; Owings JT; Zhou J; Wun T
    Am J Clin Pathol; 2007 Mar; 127(3):429-33. PubMed ID: 17276943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
    Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J
    Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
    Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
    Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
    Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
    Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 32. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG; Tomaski A; Pollak ES
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
    Dellaria SM; Greilich PE; Sarode R
    Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
    Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of PF4-heparin auto-antibodies by ELISA.
    Woodhams BJ; Grimaux M
    Thromb Haemost; 1999 Jul; 82(1):157-8. PubMed ID: 10456477
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcome of patients with positive heparin-platelet factor-4 antibodies: A retrospective multi-institutional observational study.
    Tapan U; Bolla S; Daglilar ES; Chang S; Kozyreva O
    Platelets; 2015; 26(7):661-4. PubMed ID: 25383658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
    Selleng K; Warkentin TE; Sheppard JA; Greinacher A
    Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anaphylactoid reactions associated with contaminated heparin from China].
    Montpas N; Désormeaux A; Keire D; Adam A
    Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between platelet factor 4/heparin complexes ELISA and platelet aggregation test in heparin-induced thrombocytopenia.
    Nguyên P; Droullé C; Potron G
    Thromb Haemost; 1995 Aug; 74(2):804-5. PubMed ID: 8585032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.